Stock listing

Genetic Signatures Ltd.

Selected listing: GSS · ASX · AUD · AU

Genetic Signatures Ltd. (ASX:GSS), Commercial Services. Latest release Oct 8, 2026: Quarterly Activities/Appendix 4C Cash Flow Report.

GSS:ASXAUDAUUpdated October 2, 2026
Genetic Signatures Ltd. logo
Ticker
ASX:GSS
Asset type
Stock
Sector
Commercial Services
Industry
Miscellaneous Commercial Services
Exchange
ASX
Currency
AUD

About Genetic Signatures Ltd.

The company focuses on developing and commercializing innovative molecular diagnostic solutions. Its products aim to enhance the detection of infectious diseases and improve patient outcomes.

Latest news from Genetic Signatures Ltd.

Quarterly Activities/Appendix 4C Cash Flow Report

October 7, 2026

GSS Investor Presentation - Proposed Merger with MAP

September 21, 2026

Receipt of Section 249D Notice from BCAL Diagnostics

September 16, 2026

BDX Holdings of GSS Shares and receipt of Section 249D

September 2, 2026

Genetic Signatures and Microba in Merger Discussions

August 25, 2026

All Genetic Signatures Ltd. news →

Events

Replays

  • Genetic Signatures Limited (GSS) Q4 2026 Earnings Call

    Tue, Aug 25, 2026 · 08:00 PM ET

    Watch

  • Genetic Signatures Limited (GSS) Q2 2026 Earnings Call

    Thu, Feb 26, 2026 · 10:00 AM ET

    Watch

  • Genetic Signatures Limited (GSS) Q4 2025 Earnings Call

    Sun, Aug 24, 2025 · 12:00 AM ET

    Watch

Research Genetic Signatures Ltd.

Genetic Signatures Ltd. company profile

View the public company page for Genetic Signatures Ltd. on 6ix.

Genetic Signatures Ltd. news

Read company news and market updates connected to Genetic Signatures Ltd..

Genetic Signatures Ltd. investor events

Find investor webinars, events, and replay context for Genetic Signatures Ltd..